Susan V. DiMeo

Statistics

Publications

Citations

189

H-Index

Active since

2002

Affiliations

Bristol-Myers Squibb (United States)(Current)

Experimental Station

Susan V. DiMeo is an author at Bristol-Myers Squibb (United States) specializing in cyclin-dependent kinases, medicinal chemistry, and heterocyclic chemistry.

Publications per year

2002–2005

Publications

Matrix metalloproteinase–activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity

Charles F. Albright, Nilsa Graciani, Wei Han et al. · Molecular Cancer Therapeutics · 2005 · 104 citations

Medicine, Oncology, Pharmacology +17

Synthesis and Evaluation of Indenopyrazoles as Cyclin-Dependent Kinase Inhibitors. 3. Structure Activity Relationships at C3

Eddy W. Yue, C. Anne Higley, Susan V. DiMeo et al. · Journal of Medicinal Chemistry · 2002 · 47 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +16

Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3

Eddy W. Yue, Susan V. DiMeo, C. Anne Higley et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 38 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +12

1–3 of 3